Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000537683 | SCV000626888 | likely benign | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001015756 | SCV001176624 | likely benign | Hereditary cancer-predisposing syndrome | 2019-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003960264 | SCV004767393 | likely benign | VHL-related disorder | 2019-07-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV004003775 | SCV004836219 | likely benign | Von Hippel-Lindau syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |